You are here

  • Home
  • Archive
  • Volume 44, Issue 4
  • The effects of the 5-HT2C agonist m-chlorophenylpiperazine on elite athletes with unexplained underperformance syndrome (overtraining)

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF
Original article
The effects of the 5-HT2C agonist m-chlorophenylpiperazine on elite athletes with unexplained underperformance syndrome (overtraining)

Authors

  1. Correspondence to: Linda M Castell, Green Templeton College, University of Oxford, Oxford OX2 6HG, UK; lindy.castell{at}nda.ox.ac.uk
View Full Text

Citation

Budgett R, Hiscock N, Arida R, et al
The effects of the 5-HT2C agonist m-chlorophenylpiperazine on elite athletes with unexplained underperformance syndrome (overtraining)
British Journal of Sports Medicine 2010;44:280-283.

Publication history

  • Accepted March 19, 2008
  • First published May 16, 2008.
Online issue publication 
October 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions